CClinicalTrials.gg
CompletedNCT05252247Updated Feb 6, 2023

The Effects of Immobilisation and Exercise on Homeostatic Plasticity Mechanisms in Healthy Participants

An interventional study of Immobilisation and Exercise in Healthy, sponsored by Aalborg University. Completed at 1 site in Denmark. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-06.

Sponsored by Aalborg University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Homeostasis is important for maintaining a stable equilibrium of e.g., blood pressure, hormonal release, and release of neurotransmitters. Within the healthy brain, homeostatic plasticity mechanisms ensure stability in synaptic plasticity that maintains cortical excitability within a normal physiological range, while this regulation has been shown to be impaired in chronic pain conditions such as low back pain. Cortical excitability can also be decreased and increased experimentally, using immobilisation and exercise paradigms, respectively, yet it is unknown if this overall change in excitability is caused by a shift in homeostatic plasticity regulation. Investigating if immobilisation and exercise influences homeostatic plasticity responses, may therefore reveal important information on the malleability of homeostatic plasticity mechanisms and ways to modulate them.

Read the detailed description

The aim of this study is to investigate the impact of upper limb immobilisation and physical exercise of the hand on homeostatic plasticity in healthy individuals.

The study will be performed as a randomised cross-over study where each participant take part in three sessions, separated by approximately 24 hours. During each session, the participant will answer questionnaires and undergo quantitative sensory testing (QST). Baseline measures is obtained using transcranial magnetic stimulation (TMS)-induced motor evoked potentials (MEPs), which is done before the induction of homeostatic plasticity using transcranial direct current stimulation (tDCS). MEPs are then obtained every 10 minutes for 30 minutes. Lastly, QST measures are obtained again.

As no previous studies have investigated the effect of immobilisation and exercise on homeostatic plasticity response, a sample size calculation was estimated based on MEP analysis from a previous study using α of 0.05, β of 0.80, and effect size of 0.29, yielding 22 participants. This is consistent with recent exploratory research that suggested that up to 28 participants would be needed. Therefore, the current study aimed at including 28 participants with an interim analysis performed after 10-15 inclusions.

Each participant will attend three identical experimental sessions on the same time on three consecutive days. Eight hours before attending the experimental sessions with immobilisation the participant will be fitted a splint (MANU-Hit DIGITUS POLLEX, Clinical Innovations, DK) to immobilise the right hand. Similarly, eight hours before attending the exercise session, the participant will be instructed to perform 150 ballistic finger movements with a pace of 0.5 Hz. During the experiment, the participant will be seated comfortably with arms and hands at rest. Electromyography electrodes will be placed on the right first interosseous muscle to assess the corticomotor excitability by recording of TMS induced MEPs on the left primary motor cortex. A neoprene cap will then be mounted to the head, and the optimal site for TMS (hotspot) will be identified and marked on the cap for standardisation. The cortical excitability will be measured before and immediately after homeostatic plasticity induction (time point 0-min), and then every 10 minutes for 30 minutes.

Homeostatic plasticity will be induced using tDCS applied to the left primary motor cortex for 7 minutes, followed by a break of 3 minutes and another 5 minutes of tDCS. A constant current of 1mA will be transmitted through the tDCS system (Starstim 32, Neuroelectrics, Barcelona, Spain) using two gelled electrodes placed into holes of a neoprene cap at the position of C3 and Fp2.

The distribution of the data will be tested using a Shapiro-Wilk's test of normality. To investigate the effect of immobilisation and exercise on homeostatic plasticity, a two-way repeated measures analysis of variance (RM-ANOVA) will be conducted with factors Session (Session 1, session 2, and session 3) and Time (baseline, 0 min, 10 min, 20min, and 30 min) and a P value of \<0.05 will be considered statistically significant. Adjustments will be made for multiple post-hoc comparisons using appropriate corrections.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

Aalborg University is the lead sponsor of 178 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

o Healthy, aged between 18-60 years, right-handed, and can speak, read, and understand Danish or English

Exclusion criteria

Exclusion Criteria:

  • Pregnant or breastfeeding
  • Regular use of cannabis, opioids or other drugs (except contraceptives)
  • Current or previous neurologic, musculoskeletal, mental, or other illnesses (e.g. brain or spinal cord injuries, degenerative neurological disorders, epilepsy, major depression, cardiovascular disease, chronic lung disease, etc.)
  • Current or previous chronic or recurrent pain condition
  • Current regular use of analgesic medication or other medication which may affect the trial (including paracetamol and NSAIDs)
  • Lack of ability to cooperate
  • Recent history of acute pain particularly in the lower limbs (unless related to low back pain in patients included in sub-project 6)
  • Abnormally disrupted sleep in 24 hours preceding experiment
  • Any medical or other condition (i.e. musculoskeletal, cardiorespiratory, neurological, etc.)
  • Contraindications to TMS application (history of epilepsy, metal implants in head or jaw, etc.)
  • Unable to pass the "Transcranial Magnetic Stimulation Adult Safety Screen" or tDCS screening questionnaire
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Conditions

    Participants will attend three sessions where two consist of immobilisation or exercise interventions.

    Other: Immobilisation · Other: Exercise

Interventions

  • OtherImmobilisation

    Eight hours prior to attending the immobilisation session, a splint will be fitted to the hand of the participant and remain until the session start.

  • OtherExercise

    Eight hours prior to attending the exercise session, the participant will be instructed to perform 150 ballistic finger movements every hour until the session start.

06

What researchers measure

Primary outcomes

  1. Corticospinal excitability

    Change in corticospinal excitability (compared to baseline), as reflected by motor-evoked potential amplitudes induced by transcranial magnetic stimulation, after homeostatic plasticity induction

    Time frame: Immediately after [0 minutes after homeostatic plasticity induction] and every 10 minutes up until 30 minutes after [10-30 minutes after homeostatic plasticity induction]

Secondary outcomes

  1. Quantitative Sensory Testing: Cuff detection threshold

    Cuff detection threshold \[kPa\]

    Time frame: Before and 30 minutes post homeostatic plasticity induction

  2. Quantitative Sensory Testing: Cuff pain tolerance threshold

    Cuff pain tolerance threshold \[kPa\]

    Time frame: Before and 30 minutes post homeostatic plasticity induction

  3. Quantitative Sensory Testing: Conditioned pain modulation

    Conditioned pain modulation \[kPa change\]

    Time frame: Before and 30 minutes post homeostatic plasticity induction

  4. Quantitative Sensory Testing: Temporal summation of pain

    Temporal summation of pain \[pain rating; Visual analogue scale; 0-10 cm; higher scores means more pain\]

    Time frame: Before and 30 minutes post homeostatic plasticity induction

  5. Quantitative Sensory Testing: Mechanical pain threshold

    Mechanical pain threshold (pin prick) \[force required for inducing pricking pain; nM\]

    Time frame: Before and 30 minutes post homeostatic plasticity induction

  6. Quantitative Sensory Testing: Handheld algometry at right dorsal interosseous muscle

    Handheld algometry at right dorsal interosseous muscle \[kPa\]

    Time frame: Before and 30 minutes post homeostatic plasticity induction

  7. Quantitative Sensory Testing: Handheld algometry at left dorsal interosseous muscle

    Handheld algometry at left dorsal interosseous muscle \[kPa\]

    Time frame: Before and 30 minutes post homeostatic plasticity induction

  8. Quantitative Sensory Testing: Handheld algometry at right tibialis anterior muscle

    Handheld algometry at right tibialis anterior muscle \[kPa\]

    Time frame: Before and 30 minutes post homeostatic plasticity induction

  9. Questionnaires: Pittsburgh Sleep Quality Index

    Pittsburgh Sleep Quality Index (PSQI; 0-21; PSQI \> 5 means poor sleep quality)

    Time frame: Before baseline corticospinal excitability measurements

  10. Questionnaires: Pain Catastrophizing Scale

    Pain Catastrophizing Scale (PCS; 0-52; higher score means more pain catastrophizing)

    Time frame: Before baseline corticospinal excitability measurements

  11. Questionnaires: International Physical Activity Questionnaire

    International Physical Activity Questionnaire (IPAQ; resting metabolic rate multiplied by activity per minutes performed \> higher means better physical activity)

    Time frame: Before baseline corticospinal excitability measurements

  12. Questionnaires: Positive and Negative Affective Schedule

    Positive and Negative Affective Schedule - Short Form (PANAS; 10-50; higher scores = higher levels of negative or positive affect)

    Time frame: Before baseline corticospinal excitability measurements

07

Study locations

1 site
  • Aalborg University
    Aalborg, Nordjylland 9220, Denmark
08

References and documents

Publications

  • Fricke K, Seeber AA, Thirugnanasambandam N, Paulus W, Nitsche MA, Rothwell JC. Time course of the induction of homeostatic plasticity generated by repeated transcranial direct current stimulation of the human motor cortex. J Neurophysiol. 2011 Mar;105(3):1141-9. doi: 10.1152/jn.00608.2009. Epub 2010 Dec 22. PubMed 21177994 ↗
  • Thapa T, Graven-Nielsen T, Chipchase LS, Schabrun SM. Disruption of cortical synaptic homeostasis in individuals with chronic low back pain. Clin Neurophysiol. 2018 May;129(5):1090-1096. doi: 10.1016/j.clinph.2018.01.060. Epub 2018 Feb 9. PubMed 29472134 ↗
  • Thapa T, Graven-Nielsen T, Schabrun SM. Aberrant plasticity in musculoskeletal pain: a failure of homeostatic control? Exp Brain Res. 2021 Apr;239(4):1317-1326. doi: 10.1007/s00221-021-06062-3. Epub 2021 Feb 26. PubMed 33635391 ↗
  • Wittkopf PG, Larsen DB, Gregoret L, Graven-Nielsen T. Prolonged corticomotor homeostatic plasticity - Effects of different protocols and their reliability. Brain Stimul. 2021 Mar-Apr;14(2):327-329. doi: 10.1016/j.brs.2021.01.017. Epub 2021 Jan 24. No abstract available. PubMed 33503491 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05252247
Lead sponsor
Aalborg University
Responsible party
Dennis Boye Larsen (Assistant Professor, Aalborg University) — Principal investigator
First posted
Feb 23, 2022
Start date
Feb 15, 2022
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Feb 6, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion